Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lorazepam versus mirtazapine for insomnia in patients with metastatic cancer
IRCT20240824062854N1Phase 4Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of lorazepam and mirtazapine in Insomnia and sleep disorder (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Improvement in questionnaire score and Improvement in sleep quality questionnaire score. Started Nov 2024; status: completed.
02
Drugs
lorazepammirtazapine
03
Conditions
Insomniasleep disorder
Beyond the preview
Go deeper on IRCT20240824062854N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240824062854N1.